Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Patrick Gould
Institutions:
Memorial Sloan Kettering Cancer Center,
Columbia University Irving Medical Center
Observed institutions:
Westchester Medical Center,
Memorial Sloan Kettering Cancer Center,
Columbia University Irving Medical Center,
Maastricht University Medical Centre,
Maastricht University,
Keimyung University Dongsan Medical Center,
Columbia University
show all 7
OpenAlex ID:
A5114078273
The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin
2024
·
Edward R Scheffer Cliff
, Guido D Pelaez
, et al.
·
Blood
·
4
PDF
Posttransplant rituximab exposure and risk of PTLD in solid organ transplant recipients with EBV DNAemia
2025
·
Evelyn H. Orlando
, Patrick Gould
, et al.
·
Blood Neoplasia
·
2
Treatment intensity, illness burden, and disparities in newly diagnosed diffuse large B-cell lymphoma treated at an urban academic center
2026
·
Hua-Jay J. Cherng
, David DeStephano
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma
2025
·
Varun Iyengar
, Jomel Meeko Manzano
, et al.
·
Blood
·
1
Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes
2026
·
Patrick Gould
, Devyn Coskey
, et al.
·
Haematologica
PDF
Current threshold of measurable disease in AL amyloidosis clinical trials.
2026
·
Eugene Brailovski
, Patrick Gould
, et al.
·
Journal of Clinical Oncology
Common Threshold of Measurable Disease Improperly Excludes Patients With AL Amyloidosis From Clinical Trials
2026
·
Eugene Brailovski
, Patrick Gould
, et al.
·
American Journal of Hematology
POSTER: ABCL-817 Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
2025
·
Jessica Chicola
, Jomel Meeko Manzano
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-817: Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
2025
·
Jessica Chicola
, Jomel Meeko Manzano
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant
2025
·
Brian Cuzzo
, Maegan Ford
, et al.
·
Blood Neoplasia
Diagnostic Utility of the 18f-FDG PET/CT Scan in Solid Organ Transplant Patients with EBV Reactivation at Risk for Post-Transplant Lymphoproliferative Disorder
2024
·
Hua-Jay J Cherng
, Rebecca Scalabrino
, et al.
·
Blood
PDF
The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder
2023
·
Evelyn H. Orlando
, Patrick Gould
, et al.
·
Blood
ABCL-600 Diagnostic Utility of the 18F-FDG PET/CT Scan in EBV-Positive Solid Organ Transplant Patients at Risk for Post-Transplant Lymphoproliferative Disorder
2023
·
Hua-Jay Cherng
, Kathleen Capaccione
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PDF
POSTER: ABCL-600 Diagnostic Utility of the 18F-FDG PET/CT Scan in EBV-Positive Solid Organ Transplant Patients at Risk for Post-Transplant Lymphoproliferative Disorder
2023
·
Hua-Jay Cherng
, Kathleen Capaccione
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PDF
Show more works
View as search
Works count:
14
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type